Featured Webinars

  1. New ICH GCP Changes Center The Patient 11/7/2025

    Learn how the updated ICH GCP E6(R3) guidelines are transforming clinical trials with a focus on patient centricity, digital innovation, and risk-based quality management.

  2. Clinical Trial Disclosure Fundamentals 11/7/2025

    Failing to comply with disclosure rules can leave sponsors open to fines and penalties. Here, we present the latest disclosure requirements, enforcement mechanisms, and tips on how best to stay compliant.

  3. Expectations For Plain Language Summaries Continue To Evolve 11/7/2025

    Plain language summaries (PLS) are growing in importance as a requirement in global transparency. Focusing on protocol and results summaries, we cover expectations and best practices for global PLS implementation.

  4. Reassure Patients About Benefits Of Clinical Trial Participation 10/29/2025

    Gaining a patient’s trust is the first step to trial participation. Find out how to address this in From Cautious to Committed, the first of a three-part webinar series covering strategies across the patient recruitment continuum.

  5. The Latest Generation Of Patient Recruitment Has Arrived 10/29/2025

    In the final session of our three-part webinar series, we explore what this next phase of evolution means for clinical trial planning and execution, and examine how innovative approaches are reshaping recruitment strategies from the ground up.

  6. Use Data For Fit-For-Purpose Patient Recruitment Strategy 10/29/2025

    Learn how a proactive, data-integrated approach can transform patient recruitment from a reactive hurdle into a built-in advantage — accelerating enrollment, improving representativeness, and setting studies up for success from day one.

  7. No Statistically Significant Progress — Yet 10/20/2025

    Dr. Jennifer E. Miller of the Yale School of Medicine says her Good Pharma Scorecard found no statistically significant diversity improvements in oncology trials over the past decade, despite decades of policy efforts and major investments.

  8. Community Trust Can't Be Outsourced 10/20/2025

    Dr. Brescher underscores that authentic community trust can’t come from corporate messaging alone. It grows when people from within the community lead research conversations and build relationships grounded in shared experience.

  9. What Bright Spots In Trial Diversity Are Doing Differently 10/20/2025

    According to Dr. Miller, the “bright spot” sponsors making real progress are those abandoning one-size-fits-all vendors, investing in patient navigators, and leveraging broader site networks to improve representation across studies.

  10. The Real Story Behind SOGI Data In Clinical Trials 10/20/2025

    In this clip, Dr. Jessica Brecher of Tectonic Therapeutic reveals why many trial sites refuse to activate sexual-orientation and gender-identity (SOGI) questions — from investigator discomfort to patient fears — and why collecting these data is scientifically essential.